Stillbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds

Oncology Reports

Volumn 19, Issue 3, 2008, Pages 801-810

  Bader, Yvonne ^a   Madlener, Sibylle ^a   Strasser, Stephan ^a   Maier, Susanne ^a   Saiko, Philipp ^a   Stark, Nicole ^a   Popescu, Ruxandra ^a,b   Huber, Daniela ^a   Golliger, Michaela ^a   Erker, Thomas ^b   Handler, Norbert ^b   Szakmary, Akos ^a   Jäger, Walter ^b   Kopp, Brigitte ^b   Tentes, Ioannis ^c   Fritzer Szekeres, Monika ^a   Krupitza, Georg ^a   Szekeres, Thomas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

Author keywords

Breast cancer; Chemoresistance; erbB2; Methoxylated resveratrol analogue; p53

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; CYTARABINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLOXURIDINE; M 5; PROTEIN P53; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; 3,4',5-TRIMETHOXYSTILBENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER RESISTANCE; CELL CLONING; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG RESISTANCE; DRUG STRUCTURE; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; LONG TERM CARE; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; BREAST TUMOR; CELL CLONE; CELL CYCLE; CHEMISTRY; DRUG EFFECT; FEMALE; GENETICS; PATHOLOGY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CLONE CELLS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, ERBB-2; GENES, P53; HUMANS; STILBENES;

EID: 40249096486     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)